[Congressional Record Volume 166, Number 214 (Thursday, December 17, 2020)]
[Senate]
[Pages S7641-S7642]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




      UNITED STATES ANTI-DOPING AGENCY REAUTHORIZATION ACT OF 2020

  Mr. BRAUN. Mr. President, I ask unanimous consent that the Senate 
proceed to the immediate consideration of Calendar No. 594, S. 3248.
  The PRESIDING OFFICER. The clerk will report the bill by title.
  The senior assistant legislative clerk read as follows:

       A bill (S. 3248) to reauthorize the United States Anti-
     Doping Agency, and for other purposes.

  There being no objection, the Senate proceeded to consider the bill 
which had been reported from the Committee on Commerce, Science, and 
Transportation, with amendments, as follows:
  (The parts of the bill intended to be stricken are shown in boldface 
brackets, and the parts of the bill intended to be inserted are shown 
in italics.

                                S. 3248

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``United States Anti-Doping 
     Agency Reauthorization Act of 2020''.

     SEC. 2. FINDINGS.

       Congress makes the following findings:
       (1) The United States Anti-Doping Agency--
       (A) is the independent national anti-doping organization of 
     the United States; and
       (B) manages the anti-doping program, results management 
     processes, drug reference resources, and athlete education 
     for all United States Olympic Committee-recognized national 
     governing bodies and the athletes and events of such national 
     governing bodies.
       (2) The United States Anti-Doping Agency contributes to the 
     advancement of clean sport through scientific research, anti-
     doping education, and outreach programs, and the mission of 
     the United States Anti-Doping Agency is to preserve the 
     integrity of competition and protect the rights of athletes.
       (3) Participation in youth sports has the potential to 
     equip young athletes with important skills and values 
     necessary for success in life, and it is essential that the 
     culture of youth sports emphasizes such skills and values.
       (4) The TrueSport program of the United States Anti-Doping 
     Agency partners with youth sport organizations across the 
     United States to promote sportsmanship, character building, 
     and healthy performance through the use of targeted 
     educational materials designed to promote a positive youth 
     sport experience.
       (5) In modifying the authority of the United States Anti-
     Doping Agency to include the promotion of the positive values 
     of youth sport, Congress sends a strong signal that the goals 
     of youth sport should include instilling in young athletes 
     the values of integrity, respect, teamwork, courage, and 
     responsibility.
       (6) Due to the unique leadership position of the United 
     States in the global community, adequate funding of the anti-
     doping and clean sport programs of the United States Anti-
     Doping Agency is imperative to the preparation for the 2028 
     Summer Olympic Games, which will be held in Los Angeles, 
     California.
       [(7) Increased appropriations for fiscal years 2021 through 
     2029 would enable the United States Anti-Doping Agency to 
     directly affect the integrity and well-being of sport, both 
     domestically and internationally.]

     SEC. 3. PROMOTION OF YOUTH SPORTS.

       Section 701(b) of the Office of National Drug Control 
     Policy Reauthorization Act of 2006 (21 U.S.C. 2001(b)) is 
     amended--
       (1) in paragraph (4), by striking the period at the end and 
     inserting ``; and''; and
       (2) by adding at the end the following:
       ``(5) promote a positive youth sport experience [1by using 
     a portion of the funding of the United States Anti-Doping 
     Agency to provide educational] by providing educational 
     materials on sportsmanship, character building, and healthy 
     performance for the athletes, parents, and coaches who 
     participate in youth sports.''.

     SEC. 4. AUTHORIZATION OF APPROPRIATIONS.

       Section 703 of the Office of National Drug Control Policy 
     Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to 
     read as follows:

     ``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

       ``There are authorized to be appropriated to the United 
     States Anti-Doping Agency--
       ``(1) for fiscal year 2021, $15,500,000;
       ``(2) for fiscal year 2022, $16,200,000;
       ``(3) for fiscal year 2023, $16,900,000;
       ``(4) for fiscal year 2024, $17,700,000;
       ``(5) for fiscal year 2025, $18,500,000;
       ``(6) for fiscal year 2026, $19,800,000;
       ``(7) for fiscal year 2027, $22,100,000;
       ``(8) for fiscal year 2028, $24,900,000; and
       ``(9) for fiscal year 2029, $23,700,000.''.

     SEC. 5. INFORMATION SHARING.

       Except as otherwise prohibited by law and except in cases 
     in which the integrity of a criminal investigation would be 
     affected, pursuant to the obligation of the United States 
     under Article 7 of the United Nations Educational, 
     Scientific, and Cultural Organization International 
     Convention Against Doping in Sport done at Paris October 19, 
     2005, and ratified by the United States in 2008, the Attorney 
     General, the Secretary of Homeland Security, and the 
     Commissioner of Food and Drugs shall provide to the United 
     States Anti-Doping Agency any relevant information relating 
     to the prevention of the use of performance-enhancing drugs 
     or the prohibition of performance-enhancing methods.

     SEC. 6. REPORT ON CAPACITY TO IMPLEMENT EQUINE ANTI-DOPING 
                   AND MEDICATION CONTROL PROGRAM.

       Not later than 180 days after the date of the enactment of 
     this Act, the United States Anti-Doping Agency shall submit 
     to Congress a report that--
       (1) assesses the capacity of the United States Anti-Doping 
     Agency to implement an equine anti-doping and medication 
     control program; and
       (2) includes--
       (A) recommendations with respect to best practices for 
     design, resources, and any other consideration necessary for 
     the successful implementation of such a program in the United 
     States; and
       (B) recommendations developed in consultation with the 
     National Veterinary Services Laboratories with respect to the 
     appropriate technical standards and best practices for such a 
     program.

  Mr. BRAUN. I ask unanimous consent that the committee-reported 
amendments be withdrawn; that the Moran substitute amendment at the 
desk be agreed to; that the bill, as amended, be considered read a 
third time and passed; and the motion to reconsider be considered made 
and laid upon the table.
  The PRESIDING OFFICER. Without objection, it is so ordered.

[[Page S7642]]

  The committee-reported amendments were withdrawn.
  The amendment (No. 2715) in the nature of a substitute was agreed to, 
as follows

                (Purpose: In the nature of a substitute)

        Strike all after the enacting clause and insert the 
     following:

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``United States Anti-Doping 
     Agency Reauthorization Act of 2020''.

     SEC. 2. FINDINGS.

       Congress makes the following findings:
       (1) The United States Anti-Doping Agency--
       (A) is the independent national anti-doping organization of 
     the United States; and
       (B) manages the anti-doping program, results management 
     processes, drug reference resources, and athlete education 
     for all United States Olympic Committee-recognized national 
     governing bodies and the athletes and events of such national 
     governing bodies.
       (2) The United States Anti-Doping Agency contributes to the 
     advancement of clean sport through scientific research, anti-
     doping education, and outreach programs, and the mission of 
     the United States Anti-Doping Agency is to preserve the 
     integrity of competition and protect the rights of athletes.
       (3) Participation in youth sports has the potential to 
     equip young athletes with important skills and values 
     necessary for success in life, and it is essential that the 
     culture of youth sports emphasizes such skills and values.
       (4) The TrueSport program of the United States Anti-Doping 
     Agency partners with youth sport organizations across the 
     United States to promote sportsmanship, character building, 
     and healthy performance through the use of targeted 
     educational materials designed to promote a positive youth 
     sport experience.
       (5) In modifying the authority of the United States Anti-
     Doping Agency to include the promotion of the positive values 
     of youth sport, Congress sends a strong signal that the goals 
     of youth sport should include instilling in young athletes 
     the values of integrity, respect, teamwork, courage, and 
     responsibility.
       (6) Due to the unique leadership position of the United 
     States in the global community, adequate funding of the anti-
     doping and clean sport programs of the United States Anti-
     Doping Agency is imperative to the preparation for the 2028 
     Summer Olympic Games, which will be held in Los Angeles, 
     California.
       (7) Increased appropriations for fiscal years 2021 through 
     2029 would enable the United States Anti-Doping Agency to 
     directly affect the integrity and well-being of sport, both 
     domestically and internationally.

     SEC. 3. MODIFICATIONS OF AUTHORITY.

       Section 701 of the Office of National Drug Control Policy 
     Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
       (1) in subsection (b)--
       (A) by amending paragraph (1) to read as follows:
       ``(1)(A) serve as the independent anti-doping organization 
     for the amateur athletic competitions recognized by the 
     United States Olympic and Paralympic Committee;
       ``(B) be responsible for certifying in advance any testing 
     conducted by international organizations under the World 
     Anti-Doping Code for international amateur athletes and 
     athletic competitions occurring within the jurisdiction of 
     the United States; and
       ``(C) be recognized worldwide as the independent national 
     anti-doping organization for the United States;'';
       (B) in paragraph (4), by striking the period at the end and 
     inserting ``; and''; and
       (C) by adding at the end the following:
       ``(5) promote a positive youth sport experience by using a 
     portion of the funding of the United States Anti-Doping 
     Agency to provide educational materials on sportsmanship, 
     character building, and healthy performance for the athletes, 
     parents, and coaches who participate in youth sports.''; and
       (2) by adding at the end the following:
       ``(c) Due Process in Arbitration Proceedings.--Any action 
     taken by the United States Anti-Doping Agency to enforce a 
     policy, procedure, or requirement of the United States Anti-
     Doping Agency against a person with respect to a violation of 
     Federal law, including an investigation, a disciplinary 
     action, a sanction, or any other administrative action, shall 
     be carried out in a manner that provides due process 
     protection to the person.''.

     SEC. 4. AUTHORIZATION OF APPROPRIATIONS.

       Section 703 of the Office of National Drug Control Policy 
     Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to 
     read as follows:

     ``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

       ``There are authorized to be appropriated to the United 
     States Anti-Doping Agency--
       ``(1) for fiscal year 2021, $15,500,000;
       ``(2) for fiscal year 2022, $16,200,000;
       ``(3) for fiscal year 2023, $16,900,000;
       ``(4) for fiscal year 2024, $17,700,000;
       ``(5) for fiscal year 2025, $18,500,000;
       ``(6) for fiscal year 2026, $19,800,000;
       ``(7) for fiscal year 2027, $22,100,000;
       ``(8) for fiscal year 2028, $24,900,000; and
       ``(9) for fiscal year 2029, $23,700,000.''.

     SEC. 5. INFORMATION SHARING.

       Except as otherwise prohibited by law and except in cases 
     in which the integrity of a criminal investigation would be 
     affected, pursuant to the obligation of the United States 
     under Article 7 of the United Nations Educational, 
     Scientific, and Cultural Organization International 
     Convention Against Doping in Sport done at Paris October 19, 
     2005, and ratified by the United States in 2008, the Attorney 
     General, the Secretary of Homeland Security, and the 
     Commissioner of Food and Drugs shall provide to the United 
     States Anti-Doping Agency any relevant information relating 
     to the prevention of the use of performance-enhancing drugs 
     or the prohibition of performance-enhancing methods.

  The bill (S. 3248), as amended, was ordered to be engrossed for a 
third reading, was read the third time, and passed.

                          ____________________